Analysis of fatal cases according to COVID-hospital data
https://doi.org/10.30629/0023-2149-2022-100-4-5-214-220
Abstract
New coronavirus infection (COVID-19) hospital mortality rate is high but vary in different countries. The aim of the study: to analyze the mortality in the COVID-hospital for the period from January to December 2021 taking into account the age as well as the causes of deaths and comorbidity of patients who died in January–February 2021. Material and methods. Hospital mortality was evaluated according to the registers in 2021. The case histories of patients who died in January–February 2021 were analyzed retrospectively. Results. 984 pa of patients over 60 years old (14.38%) was higher compared to younger people (3.98%), and increased with age. The most frequent complications in 84 patients who died in January–February were acute respiratory distress syndrome, infectious-toxic shock, acute cerebrovascular accident. 78 (92.85%) of the deceased had 2 or more concomitant diseases. Cardiac pathology, chronic kidney disease and diseases of the endocrine system were the leaders in frequency. Vaccination for the previous 6 months was carried out in 3 (3.57%) patients. Conclusion. Mortality rate in the COVID-hospital in 2021 was 10.49% and was significantly higher among patients over 60 years old. A further increase in age was associated with an increase in mortality. The majority of the patients, 78 out of 84 (92.85%) who died in January–February, had multimorbidity.
About the Authors
M. S. Smirnova
Privolzhsky Research Medical University of the Ministry of Health of Russia,
Russian Federation
Russian Federation
603005, Nizhny Novgorod
A. V. Smirnov
Bor Central Regional Hospital
Russian Federation
Russian Federation
606440, Bor
O. A. Smirnova
Bor Central Regional Hospital
Russian Federation
Russian Federation
606440, Bor
K. A. Medvedev
Privolzhsky Research Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
603005, Nizhny Novgorod
References
1. Peralta I.M.G., De Llano L.P., Romay-Lema E., Villar A.B., Diaz C.A., Durán M.T. et al. COVID-19 pneumonia in Galicia (Spain): impact of prognostic factors and therapies on mortality and need for mechanical ventilation. ERJ. 2021;58:3808. DOI: 10.1183/13993003.congress-2021.PA3808
2. Verma A.A., Hora T., Jung H.Y., Fralick M., Malecki S.L., Lapointe-Shaw L. et al. Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area. CMAJ. 2021;193(12):E410–E418. DOI: 10.1503/cmaj.202795
3. Richardson S., Hirsch J.S., Davidson K.W. Presenting, Char ac teristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052–2059. DOI: 10.1001/jama.2020.6775
4. Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L. et al. Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369: m1985. DOI: 10.1136/bmj.m1985
5. Ghribi W., Fehri S.M., Euch D.E., Abdelmouleh K., Gnounou A., Ghorbel H., Kwass H. Predictors of COVID-19-related mortality: experience of the isolation unit at the Gabes regional hospital. ERJ. 2021;58:PA3821. DOI: 10.1183/13993003.congress-2021.PA382
6. Frent S.M., Bikov A., Bobu E., Pleava R., Serban C., Marincu I., Marc M., Mihaicuta S., Oancea C. Mortality risk in a Romanian cohort of patients hospitalised for COVID-19. ERJ. 2021;58:PA3815. DOI: 10.1183/13993003.congress-2021.PA3815
7. Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г., Беленков Ю.Н., Конради А.О., Лопатин Ю.М. и соавт. Международный регистр «Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2» (АКТИВ SARS-CoV-2): анализ предикторов неблагоприятных исходов острой стадии новой коронавирусной инфекции. Российский кардиологический журнал. 2021;26(4):116–131. [Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., Belenkov Yu.N., Konradi A.O., Lopatin Yu.M. et al. International Register "Dynamics Analysis Comorbid diseases in patients who have been infected with SARSCoV-2" (ACTIVE SARS-CoV-2): analysis of predictors of adverse outcomes of the acute stage of a new coronavirus infection. Russian Journal of Cardiology. 2021;26(4):116–131. (In Russian)]. DOI: 10.15829/1560-4071-2021-4470
8. Niforatos J.D, Melnick E.R., Faust J.S. Covid-19 fatality is likely overestimated. BMJ. 2020;368:m1113. DOI: 10.1136/bmj.m1113
9. Liu Y., Mao B., Liang S., Yang J.W., Lu H.W., Chai Y.H. et al. Association between age and clinical characteristics and outcomes of COVID-19. ERJ. 2020;55:2001112. DOI: 10.1183/13993003.01112-2020
10. Tessitore E., Carballo D., Poncet A., Perrin N., Follonier C., Assouline B. et al. Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease. Open Heart. 2021;8:e001526. DOI: 10.1136/openhrt-2020-001526 11. Du R.H., Liang L.-R., Yang C.Q., Wang W., Cao T.Z. et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. ERJ. 2020;55:2000524. DOI: 10.1183/13993003.50524-2020
11. Guan W.J., Liang W.H., Zhao Y., Liang H.R., Chen Z.S., Li Y.M. et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. ERJ. 2020;55:2000547. DOI: 10.1183/13993003.00547-2020
12. Beltramo G., Cottenet J., Mariet A.-S., Georges M., Piroth L., Tubert-Bitter P., Bonniaud P., Quantin C. Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study. ERJ. 2021;58:2004474. DOI: 10.1183/13993003.04474-2020
13. Piroth L., Cottenet J., Mariet A.-S., Bonniaud P., Blot M., TubertBitter M. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, populationbased retrospective cohort study. Lancet Infect. Dis. 2020;20:e238–e244. DOI: 10.1016/S2213-2600(20)30527-0
14. Mehra M.R., Desai S.S., Kuy S.R., Henry T.D., Patel A.N. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N. Engl. J. Med. 2020;382:e102. DOI: 10.1056/NEJMoa2007621
15. Ahrenfeldt L.J., Nielsen C.R., Möller S.K. Burden and prevalence of risk factors for severe COVID-19 disease in the ageing European population — a SHARE-based analysis. J. Public Health. 2021; in press. DOI: 10.1007/s10389-021-01537-7
Review
For citations:
Smirnova M.S., Smirnov A.V., Smirnova O.A., Medvedev K.A. Analysis of fatal cases according to COVID-hospital data. Clinical Medicine (Russian Journal). 2022;100(4-5):214-220. (In Russ.) https://doi.org/10.30629/0023-2149-2022-100-4-5-214-220
Views:
784
Email this article 